Julia Rotow

Harvard University

H指数:23

被引数:3,931

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes with neoadjuvant osimertinib and/or chemotherapy in patients with EGFR-mutant resectable non-small cell lung cancers

EGFR突变可切除非小细胞肺癌患者接受新辅助奥希替尼和/或化疗的疗效

Lung Cancer

IF4.4

2025-10-140

PRE

Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024

肺癌管理临床策略：2024年弥合差距肺癌共识会议的建议

Cancer

IF5.1

2025-08-260

PRE

Narjust Florez MD; Sandip Patel MD; Heather A. Wakelee MD; Julia Rotow MD; Elaine Shum MD; Jacob Sands MD; Ravi Salgia MD, PhD; Fred R. Hirsch MD, PhD; Solange Peters MD, PhD; Joshua Sabari MD; Hatim Husain MD; Lyudmila Bazhenova MD; Erminia Massarelli MD, PhD, MS; Leah M. Backhus MD, MPH; Percy Lee MD; Roy S. Herbst MD, PhD; Christine Bestvina MD; Kristin Higgins MD; Aakash Desai MD, MPH; Martin Dietrich MD, PhD; Hari Balaji Keshava MD, MS; Balazs Halmos MD, MS; David R. Gandara MD; Jonathan Wesley Riess MD, MS; Ana I. Velázquez MD, MSc; Anjali Sibley MD, MPH; Misty Shields MD, PhD; Triparna Sen PhD, MS; Edward S. Kim MD, MBA

Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer

血浆表观基因组分析揭示了前列腺癌中治疗相关的鳞状细胞转化。

npj Precision Oncology

IF8

2025-07-090

OAAI

Molecular Tumor Boards: A consensus statement from the International Association for the Study of Lung Cancer

分子肿瘤委员会：国际肺癌研究协会的共识声明

Journal of Thoracic Oncology

IF20.8

2025-07-070

PRE

Mihaela Aldea; Julia K. Rotow; Maria Arcila; Matthew Hatton; Lynette Sholl; Christian Rolfo; Marco Tagliamento; Teodora Radonic; Kurt A. Schalper; Vivek Subbiah; Umberto Malapelle; Anja C. Roden; Rami Manochakian; Ming-Sound Tsao; Helena Linardou; Rina Hui; Silvia Novello; Alastair Greystoke; Anjali Saqi; Sylvie Lantuejoul; David M. Hwang; Kelly Nevins; Murry Wynes; Saiama Waqar; Yuchen Han; Yasushi Yatabe; Wei-Chin Chang; Takuo Hayashi; Tae-Jung Kim; Paul Hofman; Fabio Tavora; Fred R. Hirsch; Valeria Denninghoff; Natasha B. Leighl; Alexander Drilon; Wendy A. Cooper; Sanja Dacic; Pranshu Mohindra; Nick Pavlakis; Fernando Lopez-Rios

Mitigation and management of adverse events associated with amivantamab therapy

与阿曼曲单抗治疗相关的不良事件缓解与管理

ONCOLOGIST

IF4.2

2025-07-010

OAAI

BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2024-10-210

OAAI

First-in-human, phase 1 study of a selective RET inhibitor, LOXO-260, in patients with RET inhibitor refractory, RET-altered cancers

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-010

PRE

Non-adenocarcinoma histology in patients with RET plus lung cancer: Response to RET-inhibitors and survival from the RET-MAP registry

RET融合阳性肺癌患者中的非腺癌组织学特征：来自RET-MAP登记研究的RET抑制剂疗效与生存分析

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer

NATURE COMMUNICATIONS

IF15.7

2024-05-0310

OAAI

Haderk, Franziska; Chou, Yu-Ting; Cech, Lauren; Fernandez-Mendez, Celia; Yu, Johnny; Olivas, Victor; Meraz, Ismail M.; Rabago, Dora Barbosa; Kerr, D. Lucas; Gomez, Carlos; Allegakoen, David V.; Guan, Juan; Shah, Khyati N.; Herrington, Kari A.; Gbenedio, Oghenekevwe M.; Nanjo, Shigeki; Majidi, Mourad; Tamaki, Whitney; Pourmoghadam, Yashar K.; Rotow, Julia K.; McCoach, Caroline E.; Riess, Jonathan W.; Gutkind, J. Silvio; Tang, Tracy T.; Post, Leonard; Huang, Bo; Santisteban, Pilar; Goodarzi, Hani; Bandyopadhyay, Sourav; Kuo, Calvin J.; Roose, Jeroen P.; Wu, Wei; Blakely, Collin M.; Roth, Jack A.; Bivona, Trever G.

A phase 1/2a, multicenter, open-label, non-randomized first-in-human study to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of DB-1310 (a HER3-targeting ADC) in patients with advanced/metastatic solid tumors

CANCER RESEARCH

IF16.6

2024-04-050

PRE

Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non-Small Cell Lung Cancer

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2024-04-010

Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report

FRONTIERS IN ONCOLOGY

IF3.3

2024-01-230

OAAI

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

NATURE GENETICS

IF31.8

2023-12-0419

OAAI

Caswell, Deborah R.; Gui, Philippe; Mayekar, Manasi K.; Law, Emily K.; Pich, Oriol; Bailey, Chris; Boumelha, Jesse; Kerr, D. Lucas; Blakely, Collin M.; Manabe, Tadashi; Martinez-Ruiz, Carlos; Bakker, Bjorn; Villcas, Juan De Dios Palomino; I. Vokes, Natalie; Dietzen, Michelle; Angelova, Mihaela; Gini, Beatrice; Tamaki, Whitney; Allegakoen, Paul; Wu, Wei; Humpton, Timothy J.; Hill, William; Tomaschko, Mona; Lu, Wei-Ting; Haderk, Franziska; Al Bakir, Maise; Nagano, Ai; Gimeno-Valiente, Francisco; Trecesson, Sophie de Carne; Vendramin, Roberto; Barbe, Vittorio; Mugabo, Miriam; Weeden, Clare E.; Rowan, Andrew; McCoach, Caroline E.; Almeida, Bruna; Green, Mary; Gomez, Carlos; Nanjo, Shigeki; Barbosa, Dora; Moore, Chris; Przewrocka, Joanna; Black, James R. M.; Gronroos, Eva; Suarez-Bonnet, Alejandro; Priestnall, Simon L.; Zverev, Caroline; Lighterness, Scott; Cormack, James; Olivas, Victor; Cech, Lauren; Andrews, Trisha; Rule, Brandon; Jiao, Yuwei; Zhang, Xinzhu; Ashford, Paul; Durfee, Cameron; Venkatesan, Subramanian; Temiz, Nuri Alpay; Tan, Lisa; Larson, Lindsay K.; Argyris, Prokopios P.; Brown, William L.; Yu, Elizabeth A.; Rotow, Julia K.; Guha, Udayan; Roper, Nitin; Yu, Johnny; Vogel, Rachel I.; Thomas, Nicholas J.; Marra, Antonio; Selenica, Pier; Yu, Helena; Bakhoum, Samuel F.; Chew, Su Kit; Reis-Filho, Jorge S.; Jamal-Hanjani, Mariam; Vousden, Karen H.; McGranahan, Nicholas; Van Allen, Eliezer M.; Kanu, Nnennaya; Harris, Reuben S.; Downward, Julian; Bivona, Trever G.; Swanton, Charles

Trial in progress: First-in-human phase I dose-escalation study of a novel Bicycle toxin conjugate (BT5528) targeting EphA2 in patients with advanced solid tumors

MOLECULAR CANCER THERAPEUTICS

IF5.5

2023-12-010

PRE

Fontana, Elisa; Bashir, Babar; Wang, Judy S.; Aljumaily, Raid; Machiels, Jean-Pascal; Vieito, Maria; Falchook, Gerald; Carter, Louise; de Speville, Bernard Doger; Greystoke, Alastair; Kim, Sang Wun; Kotecki, Nuria; Spira, Alexander I.; Candilejo, Irene Moreno; Basu, Bristi; Prenen, Hans; Bessudo, Alberto; Nagasaka, Misako; Ahnert, Jordi Rodon; Park, Joo-Hwan; Teo, Min-Yuen; Rotow, Julia; Liu, Jie; De Rienzo, Assunta; Li, Mengyao; Domingo, Adriana; Orr, Hanna; Bennett, Gavin; Sharma, Rajiv; McKean, Meredith

Clinicopathologic characteristics and outcomes to immune checkpoint inhibitor therapy in patients with HER2-altered metastatic non-small cell lung cancer

ANNALS OF ONCOLOGY

IF65.4

2023-10-010